Status:
UNKNOWN
Intranasal Dexmedetomidine Versus Intranasal Midazolam as a Premedication in Pediatrics Undergoing Upper GI Endoscopy
Lead Sponsor:
Ain Shams University
Conditions:
Anesthesia
Eligibility:
All Genders
2-6 years
Phase:
PHASE4
Brief Summary
compare the effectiveness of intranasal dexmedetomidine and midazolam as a premedication in sedation of preschool children in GI endoscopy
Eligibility Criteria
Inclusion
- Children of preschool age (2-6 years old).
- American scocity of anaesthesiology (ASA) I - II children.
- Expected duration of the procedure is less than 50 minutes.
Exclusion
- Cardiac arrhythmia, congenital heart disease, or hemodynamic or respiratory instability; children at risk for airway obstruction.
- Behavioral, mental or developmental abnormality (example: mental retardation, Attention Deficit Hyperactivity Disorder "ADHD", Autism, Down syndrome).
- Regular intake of either brain stimulant or depressive drugs (example: Methylphenidate, amphetamine-dextroamphetamine and diazepam respectively).
- Parent's refusal.
- Emergency case.
- Allergy to any of the used drugs
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06181682
Start Date
January 1 2024
End Date
March 1 2024
Last Update
December 26 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.